跳到正文
原文
NEJM· @NEJM · X·· 8 天前精选AI 评分58
AI 导读

NEJM发布TYDAL-TIMI 78 2b期试验结果,抗ANGPTL4单克隆抗体MAR001在甘油三酯升高的成人中于12周显著降低空腹甘油三酯水平。完整结果已在AHA Scientific Sessions 2026公布,并附NEJM全文链接。

推荐理由

2b期试验显示靶向ANGPTL4的单抗在12周显著降低空腹甘油三酯,为高甘油三酯人群提供新机制方向。

正文

Presented at #ScientificSessions26:

In a phase 2b trial involving adults with elevated triglyceride levels, MAR001, a monoclonal antibody against angiopoietin-like protein 4, significantly reduced fasting triglyceride levels at 12 weeks. Full TYDAL-TIMI 78 trial results: https://nej.md/4jR2PmF

@AHAScience

来源:NEJM · x.com